Trial Profile
Phase IV.III clinical trial to evaluate maintenance treatment with Caelyx versus observation after administration of induction chemotherapy in metastatic breast cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Sep 2008 Results presented at ESMO 2008.
- 03 Jun 2007 Results presented at ASCO 2007.
- 03 Jun 2007 Status changed from recruiting to in progress.